Vasiliki Aivaliotis, MD
Internal Medicine · Santa Clara
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 4
- 1 carrier
- Office
- 1
Offices
1 location · Permanente Medical Group Inc · 10,928 clinicians in this group
Plans that list them
4 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Aivaliotis’s office at (408) 851-1000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Kaiser Permanente Dual Complete North P2 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Dual Complete North P23 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Basic Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Enhanced Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
Original Medicare doctor bills
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Procedures Medicare counted
| Colonoscopy | 1-10 | None |
Drugs they prescribed that Part D paid
$433,969
Pharmacies billed $433,969 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 629) in 2024. At or below the middle of the specialty; the typical internal medicine clinician is at 1%.
569 generic and 60 brand-name prescriptions · $433,969 in drug cost · 16 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Stelara | 22 | $373,986 | $16,999 |
| Mesalamine | 25 | $14,689 | $588 |
| Gavilyte-C | 298 | $6,782 | $23 |
| Budesonide Dr | 15 | $1,617 | $108 |
| Omeprazole | 81 | $1,386 | $17 |
See all 7 drugs
| Stelara | 22 | $373,986 | $16,999 |
| Mesalamine | 25 | $14,689 | $588 |
| Gavilyte-C | 298 | $6,782 | $23 |
| Budesonide Dr | 15 | $1,617 | $108 |
| Omeprazole | 81 | $1,386 | $17 |
| Pantoprazole | 60 | $679 | $11 |
| Cholestyramine | 16 | $654 | $41 |
Year by year
| 2024 | 629 | 396 | 0% (0) | 10% | $433,969 |
| 2023 | 633 | 443 | None | 9% | $241,082 |
| 2022 | 309 | 187 | None | 29% | $99,678 |
| 2021 | 436 | 316 | 0% (0) | 19% | $77,803 |
| 2020 | 88 | 47 | 0% (0) | 24% | $10,601 |
| 2019 | 12 | None | 0% (0) | None | $3,735 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 6 drugs
| Stelara | 12 | $196,796 | $16,400 |
| Gavilyte-C | 337 | $7,130 | $21 |
| Motegrity | 12 | $6,766 | $564 |
| Budesonide Dr | 16 | $1,691 | $106 |
| Omeprazole | 97 | $1,205 | $12 |
| Pantoprazole | 33 | $330 | $10 |
2022: 6 drugs
| Mesalamine | 19 | $8,400 | $442 |
| Motegrity | 14 | $7,572 | $541 |
| Gavilyte-C | 84 | $1,377 | $16 |
| Omeprazole | 56 | $773 | $14 |
| Peg-3350 and Electrolytes | 32 | $626 | $20 |
| Pantoprazole | 27 | $302 | $11 |
2021: 7 drugs
| Linzess | 13 | $6,794 | $523 |
| Peg-3350 and Electrolytes | 111 | $2,185 | $20 |
| Gavilyte-C | 123 | $1,875 | $15 |
| Mesalamine | 11 | $1,834 | $167 |
| Omeprazole | 52 | $666 | $13 |
| Peg 3350-Electrolyte | 21 | $589 | $28 |
| Pantoprazole | 31 | $352 | $11 |
2020: 2 drugs
| Peg-3350 and Electrolytes | 14 | $316 | $23 |
| Omeprazole | 17 | $174 | $10 |
Professional record
- NPI
- 1073956439
- Trained
- University of California, San Francisco School of Medicine, 2013
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Student in a training program (390200000X)
- Mailing address
- 300 Pasteur Dr, Lane 154, Stanford, CA, 94305
- NPI first listed
- 2013-04-16
- NPI last updated
- 2021-12-17
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.